Accordingly, no significant differences in NGAL mRNA expression were observed between cancer and relative normal counterpart in all datasets analysed for each of these 4 cancer types (brain, breast, melanoma and prostate) (Figure 4, Panel B, C, K and M). The gene discussed is LCN2; the disease is cancer.